Featured
Last news
Envela Announces Dual Listing on NYSE Texas
IRVING, TX / ACCESS Newswire / May 15, 2025 / Envela Corporation today announced the dual listing of its common stock on NYSE Texas, the newly launched fully electronic equities exchange based in Dallas. The Company will maintain its primary listing on the NYSE American and will trade under the same ticker symbol, ELA, on NYSE Texas.
Applied DNA Reports Second Quarter Fiscal 2025 Financial Results
- Therapeutic DNA Production Services Segment (LineaRx) Revenues Up 44% Y/Y, Contributing to a 6% Increase in Total Revenues -- Intra-Quarter Investor Conference Call and Webcast Scheduled for June 3, 2025, at 4:30 PM ET -
TruMerit Hails Release of WHO's State of the World's Nursing Report
The report highlights a critical imperative to strengthen global nursing capacity in the wake of the pandemic and amid economic uncertainty, climate change impacts, and persistent health inequities. It warns that the global health workforce shortage will continue to widen, reaching 11 million by 2030, thereby requiring a fundamental shift in how countries approach healthcare workforce planning and investment.
A1 Group announces Acquisition of New Production Facility
COLTON, CA / ACCESS Newswire / May 15, 2025 / A1 Group, Inc. (OTC:AWON -- hereinafter referred to as the "Company"), through its wholly-owned subsidiary, AICPG, LLC, stands as a pioneering force at the intersection of technology and consumer product development, today announced the acquisition of a fully integrated beverage manufacturing facility in Toronto, Canada.
Jaguar Health Reports First Quarter 2025 Financials
The combined net Q1 2025 revenue of approximately $2.2 million for prescription and non-prescription products, including license revenue, decreased approximately 6% versus net Q1 2024 revenue of $2.4 million and 37% versus net Q4 2024 revenue of $3.5 million Mytesi prescription volume increased by approximately 1.8% in Q1 2025 over Q1 2024 and decreased by approximately 13.5% in Q1 2025 over Q4 2024REMINDER: Today Jaguar to host investor webcast at 4:15 p.m. Eastern regarding Q1 2025 financials and company updates; Click here to registerProof-of-concept (POC) results show crofelemer reduced total parenteral nutrition in patients with rare orphan diseases microvillus inclusion disease (MVID) and short bowel syndrome with intestinal failure (SBS-IF) by up to 27% and 12.5% - potential to modify disease progression in intestinal failure patients; Click here to access replay of April 30, 2025 investor webcast about results; additional POC results expected throughout 2025 for MVID and SBS-IFFDA meeting in Q2 2025 on statistically significant results of Phase 3 OnTarget trial of crofelemer in prespecified subgroup of patients with breast cancer
AGS Health Expands into Mexico with Guadalajara Location Offering Clinical Administrative Services
WASHINGTON, DC / ACCESS Newswire / May 15, 2025 / AGS Health, a leading provider of tech-enabled revenue cycle management (RCM) solutions and a strategic growth partner to healthcare providers across the U.S., announced today its expansion into Mexico with the opening of an office in Guadalajara. Taking advantage of the region's growing technology presence and a skilled medical, legal, and engineering workforce, AGS Health will hire more than 150 team members to provide Clinical Administrative Services from the new location.
New to The Street(R) Signs Skip Barber Racing School to Upgraded 12-Part National Broadcast and Media Partnership
The Closest Thing to Royalty in American Car Racing
Interactive Strength Inc. (Nasdaq:TRNR) Shares Update from CEO Q&A Featuring Both TRNR and Sportstech CEO's
Top-to-Top Conversation Offers Transparency and ConfidenceAhead of Q1 Earnings Report
Telomir Pharmaceuticals Adds Telomir-Ag2 as a Novel Drug Candidate to Pipeline Following Breakthrough Efficacy Against MARSA and Drug-Resistant Infections, Targeting a $30B+ Antimicrobial Market Opportunity
Antimicrobial resistance is recognized as one of the top global public health threats, and Telomir-Ag2 strengthens Telomir's pipeline with a differentiated candidate designed to address this urgent and expanding crisis
Luvu Brands Announces Third Quarter Fiscal 2025 Results and Strategic Growth Initiatives
ATLANTA, GA / ACCESS Newswire / May 15, 2025 / Luvu Brands, Inc. (OTCQB:LUVU), a leading designer, manufacturer, and marketer of consumer lifestyle brands, today reported financial and operational results for the third quarter of fiscal 2025, ended March 31, 2025.
The Fresh Factory Reports Record Billed Revenue & EBITDA in Q1 2025
The Company reported its highest-ever quarterly billed revenue of $10.7M (CAD $15.2M) in Q1 2025, representing a year-over-year increase of 27% from Q1 2024.The Company achieved record positive EBITDA of $0.9M (CAD $1.2M) in Q1 2025, compared to $0.3M (CAD $0.4M) in Q1 2024.The Company completed the build-out of and started production at and shipping from its new Downers Grove facility.The Company expanded its capacity and improved the packaging capabilities of its new snack-bites line.
AIML Hits Key Regulatory Benchmark with 510(k) Filing for MaxYield(TM) Signal Enhancement Platform
Proprietary neural network, cloud-based AI-powered technology designed to support clearer ECG signal interpretation across care settings.
Genflow Biosciences PLC Announces Key SIRT6 Patent Application
LONDON, UNITED KINGDOM / ACCESS Newswire / May 15, 2025 / Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company"), the only publicly listed longevity company in Europe, announces that the Japanese Patent Office has advanced its SIRT6-related patent application (Application No. JP 2024515284) to the national examination phase.
Relief Therapeutics Publishes 2025 Annual General Meeting Agenda
GENEVA, SWITZERLAND / ACCESS Newswire / May 15, 2025 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY ) (Relief), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, today published the agenda for its 2025 Annual General Meeting (AGM) of shareholders, to be held on June 12, 2025, at 10:00 a.m. CEST in Geneva, Switzerland.
Mexican influencer shot dead during live stream
A Mexican social media influencer was shot dead during a live stream on TikTok, where she had tens of thousands of followers, authorities said Wednesday.
Crypto industry praises Trump, calls for market clarity
The start of President Donald Trump's term earned rave reviews at the world's leading crypto conference Wednesday, but top industry lawyers said digital platforms wanted regulatory clarity while the Republicans control Congress.
'Assassin's Creed' no saviour for struggling Ubisoft
A bumper release for the latest "Assassin's Creed" instalment did not save French video games giant Ubisoft from falling back into the red in its 2024-25 financial year, the company said on Wednesday.
Sean Combs's ex Cassie to face defense grilling at second day in court
Sean "Diddy" Combs's former partner Casandra Ventura is expected to be grilled by the fallen music mogul's defense lawyers Wednesday as she returns to court for a second day of testimony.
Ousted Myanmar envoy charged with trespass in London residence row
Myanmar's ex-ambassador to London has been charged with trespass for refusing to leave his ambassadorial residence, police said Wednesday, after he was stripped of his post by the military junta following a 2021 coup.
Court raps Brussels for lack of transparency on von der Leyen vaccine texts
A top court Wednesday ruled the European Commission failed the transparency test by declining to release text messages sent by Ursula von der Leyen to the head of Pfizer as the bloc tried to secure Covid vaccines.
France summons cryptocurrency businesses after kidnappings
The French interior minister said Wednesday he will meet with cryptocurrency professionals to discuss how to prevent future kidnappings for ransom following several such high-profile cases in France.
S. Korea Starbucks in a froth over presidential candidates names
Starbucks in South Korea has banned customers from using the names of the country's presidential candidates -- or the disgraced ex-president -- for their orders, the coffee giant told AFP on Wednesday.
Human Rights Watch warns of migrant worker deaths in 2034 World Cup host Saudi Arabia
Human Rights Watch on Wednesday said abuses were being committed on giant construction sites in Saudi Arabia and warned of the risks to migrant workers building stadiums for the 2034 World Cup.
Judgment day in EU chief's Covid vaccine texts case
A top court is to rule Wednesday on whether the EU failed the transparency test by declining to release text messages sent by Ursula von der Leyen to the head of Pfizer as the bloc tried to secure Covid vaccines.
Misinformation clouds Sean Combs's sex trafficking trial
From doctored photos of sex-fueled parties to a racy AI-generated song, a flood of misinformation surrounding music mogul Sean "Diddy" Combs threatens to distort public perception of his closely watched New York trial.
Menendez brothers resentenced, parole now possible
Lyle and Erik Menendez, who have spent more than three decades behind bars for the grisly shotgun murders of their parents in the family's luxury Beverly Hills home, could soon walk free after a judge on Tuesday reduced their life sentences.
Aptevo Therapeutics Reports 1Q25 Financial Results And Provides an Update on Mipletamig
9 of 10 frontline AML patients achieve remission with mipletamig + standard of care across two trialsMipletamig triplet combination continues to outperform standard doublet benchmarkNo cytokine release syndrome observed in the ongoing RAINIER trial: favorable safety profile supports role in frontline AMLCohort 2 enrollment is complete, and Cohort 3 is now enrolling
Leafbuyer Technologies, Inc. Announces Quarterly Results
16% Increase in Year-Over-Year Revenue Growth and a 44% increase in Gross profit
Bausch Health Announces 2025 Annual Meeting of Shareholder Results
LAVAL, QC / ACCESS Newswire / May 14, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced the election of the 10 directors nominated at its 2025 annual meeting of shareholders ("Annual Meeting") held on May 13, 2025. The detailed results of the vote for the election of directors are set out below:
Aytu BioPharma Reports Fiscal 2025 Third Quarter Operational and Financial Results
Net income of $4.0 million, or $0.65 and $0.21 net income per share basic and diluted, respectively
CV Sciences, Inc. Reports First Quarter 2025 Financial Results
SAN DIEGO, CA / ACCESS Newswire / May 14, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for the quarter ended March 31, 2025.
Integrated BioPharma Reports Results for its Quarter Ended March 31, 2025
HILLSIDE, NJ / ACCESS Newswire / May 14, 2025 / Integrated BioPharma, Inc. ((OTCQX:INBP)) (the "Company" or "INBP") reports its financial results for the quarter ended March 31, 2025.